[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-364706-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-364706-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","pan-cancer-genetic-profiles-of-mitotic-dna-integrity-checkpoint-protein-kinases-abstract","Pan-cancer genetic profiles of mitotic DNA integrity checkpoint protein kinases - Abstract","","Pan-cancer genetic proﬁles are used to characterize protein kinases involved in the mitotic DNA integrity checkpoint signaling pathway, which regulates genomic stability in cancers. The study focuses on 16 kinase genes (ATM, BRSK1, CDK1, CDK2, CHEK1, CHEK2, MAP3K20, NEK11, PLK1, PLK2, PLK3, PRKDC, STK33, TAOK1, TAOK2, TAOK3). Multi-omic analysis across 33 cancer types evaluates SNV, CNV, methylation, mRNA expression, pathway crosstalk, and microRNA regulation networks.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/pan-cancer-genetic-profiles-of-mitotic-dna-integrity-checkpoint-protein-kinases-abstract/364706/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/pan-cancer-genetic-profiles-of-mitotic-dna-integrity-checkpoint-protein-kinases-abstract/364706.png","ImageObject",300,407,{"name":42,"@type":43},"Levi","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-02","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Which biological pathway and gene set does the study focus on?","Question",{"text":63,"@type":64},"It focuses on the mitotic DNA integrity checkpoint signaling pathway and a set of 16 protein kinase genes (ATM, BRSK1, CDK1, CDK2, CHEK1, CHEK2, MAP3K20, NEK11, PLK1, PLK2, PLK3, PRKDC, STK33, TAOK1, TAOK2, TAOK3).","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What data types and cancer coverage are analyzed to build the pan-cancer profiles?",{"text":68,"@type":64},"Multi-omic data is analyzed for the 16 genes across over 9000 samples from 33 cancer types. The profiles include SNV, CNV, methylation, mRNA expression, pathway crosstalk, and microRNA regulation networks.",{"name":70,"@type":61,"acceptedAnswer":71},"What key findings link these kinases to cancer biology?",{"text":72,"@type":64},"The SNV profile shows high mutation frequencies across several cancer types (e.g., UCEC and SKCM). CNVs correlate with survival in cancers including UCEC, KIRP, and LGG, and mRNA expression patterns may reflect regulation involving copy number, methylation, and miRNA.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},364706,1790465243,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},7971461740909,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Pan-cancer genetic proﬁles of mitotic DNA integrity checkpoint protein kinases  \nAyana Meegol Rasteh 1,2,\\#, Hengrui Liu3,4,\\#  and Panpan Wang 1  \nCancer Biomarkers Vol. 42(2): 1–15  \n© The Author(s) 2025 Article reuse guidelines: [sagepub.com/journals-permissions](sagepub.com/journals-permissions)[ ](sagepub.com/journals-permissions)DOI: 10.3233/CBM-240119 [journals.sagepub.com/home/cbm](journals.sagepub.com/home/cbm)  \nAbstract  \nBackground: The mitotic DNA integrity checkpoint signaling pathway is potentially involved in cancers that regulate genomic stability where protein kinases play a pivotal role. 16 total protein kinase genes are involved in this pathway: ATM, BRSK1, CDK1, CDK2, CHEK1, CHEK2, MAP3K20, NEK11, PLK1, PLK2, PLK3, PRKDC, STK33, TAOK1, TAOK2, and TAOK3. This study aims to provide pan-cancer proﬁles of the protein kinases in mitotic DNA integrity checkpoint signaling gene set for potential prognostic and diagnostic purposes, as well as future potential therapeutic targets for cancer in a clinical setting.  \nMethods: Multi-omic data was acquired for the 16 genes; over 9000 samples of 33 types of cancer were analyzed to create pan-cancer proﬁles of SNV, CNV, methylation, mRNA expression, pathway crosstalk, and microRNA regulation networks.  \nResults: The SNV proﬁle showed that most of these genes have a high SNV mutation frequency across some cancer types, such as UCEC and SKCM. The CNVs of some of these genes are associated with the survival of UCEC, KIRP, and LGG. BRCA, KIRC, LUAD, and STAD might be affected by the mRNA expression of these genes which might involve regulation of copy number, methylation, and miRNA. In addition, these genes also cross-talk with some known cancer pathways.  \nConclusion: The protein kinases in mitotic DNA integrity checkpoint signaling may play a role in cancer development and, with adequate research, could potentially be developed as biomarkers for cancer diagnosis and prognosis. However, further efforts are necessary to validate their clinical value for diagnosis and prognosis and to develop practical applications in clinical settings. Nevertheless, these pan-cancer proﬁles offer a better overall understanding as well as useful information for future reference regarding mitotic DNA integrity checkpoint signaling in cancer.  \nKeywords  \npan-Cancer, Genetic Proﬁles, Mitotic DNA Integrity, Protein Kinases Received: 22 April 2024; accepted: 2 September 2024  \nIntroduction  \nCancer is a complex disease that impacts many worldwide. In the United States alone, it is estimated that approximately 1,958,310 people will be newly diagnosed with cancer in 2023, and 609,820 people will die from cancer.1 Despite the recent advancements in cancer research, there is still a need for more effective treatment options. Molecular analyses have deemed that traditional categorization of cancer into groups based on the tissue where it occurs can be restrictive,2 as tumors originating from different organs can manifest similar characteristics, whilst tumors from the same organ may exhibit differences. The pan-cancer analysis allows for the comparing and contrasting of characteristics across many cancers,3 offering a comprehensive  \n1 Cancer Research Institute, Jinan University, Guangzhou, China 2Archbishop Mitty High School, San Jose, CA, USA  \n3The First Afﬁliated Hospital of Jinan University, Guangzhou, China 4Tianjin Yinuo Biomedical Co., Ltd, Tianjin, China  \n\\#  \nThese authors contribute equally.  \nCorresponding authors:  \nHengrui Liu, Cancer Research Institute, Jinan University, No. 601, Huangpu Avenue West, Tianhe District, Guangzhou City, Guangdong Province, 510632, China.  \nEmail: [lh@yinuobiomedical.cn](lh@yinuobiomedical.cn)  \nPanpan Wang, The First Afﬁliated Hospital of Jinan University. [Email: wangpp@jnu.edu.cn](Email: wangpp@jnu.edu.cn)  \nCreative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution  \nNonCommercial 4.0 Licens","cbCaitEnwtmdnZEn","https://ap.wps.com/l/cbCaitEnwtmdnZEn","pdf",5053128,15,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Introduction","[{\"question\":\"Which biological pathway and gene set does the study focus on?\",\"answer\":\"It focuses on the mitotic DNA integrity checkpoint signaling pathway and a set of 16 protein kinase genes (ATM, BRSK1, CDK1, CDK2, CHEK1, CHEK2, MAP3K20, NEK11, PLK1, PLK2, PLK3, PRKDC, STK33, TAOK1, TAOK2, TAOK3).\"},{\"question\":\"What data types and cancer coverage are analyzed to build the pan-cancer profiles?\",\"answer\":\"Multi-omic data is analyzed for the 16 genes across over 9000 samples from 33 cancer types. The profiles include SNV, CNV, methylation, mRNA expression, pathway crosstalk, and microRNA regulation networks.\"},{\"question\":\"What key findings link these kinases to cancer biology?\",\"answer\":\"The SNV profile shows high mutation frequencies across several cancer types (e.g., UCEC and SKCM). CNVs correlate with survival in cancers including UCEC, KIRP, and LGG, and mRNA expression patterns may reflect regulation involving copy number, methylation, and miRNA.\"}]","Pan-cancer genetic profiles of mitotic DNA integrity checkpoint protein kinases - Abstract | PDF",1790158802,38,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/86700723256cc71eda0319f04e368076.webp",983,1310,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/99907a8f604c6d18b9be47ce41d5891d.webp",982,1309,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4c1bfa2905cc3623e37f59dd6bfd4588.webp",981,1308,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/dbc0abba240dc48b7dd1965c3fb8e78a.webp",980,1306]